Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organon & Co. Common Stock (NY:OGN)

9.960 -0.190 (-1.87%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,377,417
Open 10.19
Bid (Size) 9.960 (1)
Ask (Size) 10.35 (1)
Prev. Close 10.15
Today's Range 9.960 - 10.23
52wk Range 8.010 - 23.10
Shares Outstanding 253,545,051
Dividend Yield 0.80%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OGN LAWSUIT ALERT: Levi & Korsinsky Notifies Organon & Co. Investors of a Class Action Lawsuit and Upcoming Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
OGN LAWSUIT ALERT: Levi & Korsinsky Notifies Organon & Co. Investors of a Class Action Lawsuit and Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit

Performance

YTD
-33.4%
-33.4%
1 Month
+4.5%
+4.5%
3 Month
-23.7%
-23.7%
6 Month
-35.5%
-35.5%
1 Year
-50.5%
-50.5%

More News

Read More
ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGN
From SkyMedia, LLC
Via GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Organon & Co. (OGN) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Notifies Shareholders of Organon & Co. (OGN) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results
Via Stocktwits
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
From Faruqi & Faruqi LLP
Via GlobeNewswire
Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain
From Organon & Co.
Via Business Wire
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGN
From Kahn Swick & Foti, LLC
Via GlobeNewswire
Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OGN
Via NewMediaWire
Topics Fraud Lawsuit
Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OGN
Via TheNewswire.com
Topics Fraud Lawsuit
OGN CLASS REMINDER: Organon & Co. is Being Sued for Securities Fraud - Contact BFA Law by July 22 if You Suffered Losses
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
OGN Stock News: Robbins LLP Reminds Organon & Co. Investors of the Pending Lead Plaintiff Deadline in the OGN Class Action – Contact Robbins LLP Before July 22 for Information
From Robbins LLP
Via GlobeNewswire
OGN DEADLINE REMINDER: Organon & Co. Investors are Reminded of the Approaching July 22 Legal Deadline - Contact BFA Law if You Lost Money
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN
Via ACCESS Newswire
ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Organon & Co. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2025 in Organon & Co. Lawsuit - OGN
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2025 in Organon & Co. Lawsuit - OGN
Via TheNewswire.com
Topics Fraud Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming Deadlines - OGN
From Pomerantz LLP
Via GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN
From The Rosen Law Firm PA
Via GlobeNewswire
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
OGN DEADLINE NOTICE: Organon & Co. Investors that Suffered Losses are Notified of the July 22 Class Action Deadline -- Contact BFA Law
Via ACCESS Newswire
Organon & Co. Class Action: Levi & Korsinsky Reminds Organon & Co. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 22, 2025 - OGN
Via TheNewswire.com
Topics Fraud Lawsuit

Frequently Asked Questions

Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 9.960
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 07/03/25 05:00 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 2.53B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.